Antidiabetic Agents
Included In This Lesson
Outline
Overview
I. Overview
A. Diabetes management
B. Goal = Normoglycemia within 2-3 months
1. Diet
2. Exercise
3. Smoking cessation
C. If not achieved with lifestyle changes
1. Medications added
II. Mechanism of Action
A. Sulfonylureas
1. Stimulating insulin secretion from the beta cells of the pancreas
B. Meglitinides
1. Stimulating insulin secretion from the beta cells of the pancreas
C. Biguanide
1. Decreasing the production of glucose / increase uptake
D. Thiazolidinediones
1. Enhancing sensitivity of insulin receptors
a. Liver, skeletal muscle and adipose tissue
E. α-Glucosidase Inhibitors
1. Delays glucose absorption
a. Blocking enzyme, α-glucosidase
III. Types
A. Sulfonylureas
1. First Generation
a. Acetohexamide
b. Chlorpropamide
c. Tolazamide
d. Tolbutamide
2. Second Generation
a. Glimepiride
b. Glipizide
c. Glyburide
B. Meglitinides
2. Repaglinide
3. Nateglinide
C. Biguanide
4. Metformin
D. Thiazolidinediones
5. Troglitazone
6. Pioglitazone
7. Rosiglitazone
E. α-Glucosidase Inhibitors
8. Acarbose
9. Miglitol
IV. Indications
A Lower the blood glucose levels
1. Diet and lifestyle changes fail
V. Contraindications
A. Drug allergy
B. Active hypoglycemia
C. Severe liver or kidney disease
1. Depending on the required metabolic pathways
D. Pregnancy
1. Insulin therapy is preferred
VI. Interactions
A. Sulfonylureas
1. Hyperglycemia
a. Alcohol
b. β-blockers
c. MAOIs
d. Oral anticoagulants
e. Sulfonamides
2. Hypoglycemia
a. Herbal supplements
i. Garlic
ii. Ginseng
B. Meglitinides
1. Increased effects
a. Fluconazole
b. NSAIDS
c. Sulfonamides
2. Reduced effects
a. Phenobarbital
b. Phenytoin
c. Carbamazepine
d. Thiazide diuretics
C. Biguanide
1. Increased effects
a. Furosemide
b. Nifedipine
2. Lactic acidosis / acute renal failure
a. Iodine-containing radiologic contrast media
D. Thiazolidinediones
1. None
E. α-Glucosidase Inhibitors
1. Hyperglycemia
a. Diuretics
b. Corticosteroids
c. Thyroid replacement hormones
d. Antiepileptic drugs
VII. Side Effects
A. Sulfonylureas
1. Agranulocytosis
2. Hemolytic anemia
3. Thrombocytopenia
B. Meglitinides
1. Headache
2. Hypoglycemia
3. Dizziness
4. Weight gain
C. Biguanide
1. Abdominal bloating
2. Nausea
3. Cramping
4. Diarrhea
D. Thiazolidinediones
1. Weight gain
2. Edema
D. α-Glucosidase Inhibitors
1. Flatulence
2. Diarrhea
3. Abdominal pain
Nursing Points
Nursing Concepts
I. Glucose metabolism
II. Pharmacology
Patient Education
I. Signs of hypoglycemia
II. Signs of hyperglycemia
Transcript
Welcome back and today we are going to cover oral antidiabetic agents.
As mentioned before, meglitinides stimulate insulin secretion (which lower blood glucose) from beta cells in the pancreas, with medications ending in -GLINIDE. Biguanides decrease the production of glucose in the liver and the #1 drug in this class is metformin. Metformin is the preferred initial pharmacologic agent for the treatment of type 2 diabetes according to the American Diabetes Association. When patients are diagnostic with diabetes (type 2), their first drug prescribed is Metformin (if lifestyle changes are not effective). It’s a great drug and at most pharmacies the drug is free of charge. Thiazolidinediones work by enhancing the insulin receptors in various places – liver, skeletal muscle and adipose tissue with drugs ending in -GLITAZONE. While a-Glucosidase inhibitors work by delaying glucose absorption (which increases blood glucose) but blocking the enzyme – with two drugs acarbose and miglitol. Antidiabetic oral agents are indicated when lowering of blood glucose is needed and lifestyle changes have failed. Now, if our goal is to lower blood glucose we have to make sure we don’t cause hypoglycemia (and cause dangerously low levels). Why is glucose important? Glucose if the primary source of energy for the body, especially the brain. Lack of the important source causes various temporary and even permanent effects (which we will discuss later in the lecture). Contraindications include allergies, hypoglycemia (as these drugs lower glucose levels), liver & kidney disease (as these drugs are metabolized or excreted using these organs) and pregnancy (as insulin is preferred – as it doesn’t cross the placenta and is safe for the baby). I had a patient who was taking an oral antidiabetic agents but kept having hypoglycemic events. The patient ended up needing to see an endocrinologist has their blood glucose level couldn’t be managed properly. An endocrinologist is a specialist who can manage patients with complicated glucose cases. Sulfonylureas have hyperglycemic interactions with combined with alcohol, beta-blockers, MAOIs, anticoagulants and sulfonamides. It also has hypoglycemic interactions with herbal supplements, mainly garlic and ginseng. If your patient is taking herbal supplements, it is important they know about these interactions as hypoglycemia can occur.
Now meglitinides will have increased and decreased effects with medications mentioned here. What does that mean? It means your patients can experience hyperglycemia (due to reduced effects and medication not being effective) or hypoglycemia (due to increased effects and medication efforts be potentiated). It is important to ask your patients what other medications they are taking as others can alter the function of the antidiabetic agents. I had a patient who was taking nateglinide and phenobarbital, as a result, their blood glucose remain elevated. Metformin’s effects will be increased with the use of furosemide and nifedipine. One unique feature of metformin is its ability to cause lactic acidosis and acute renal failure with used with iodine-containing radiologic contrast media. Contrast media is used during certain diagnostic testing, commonly computerized tomography (CT) scans are the tests. If a patient is getting a CT scan with contrast, it is recommended that metformin be withheld after the administration of the contrast agent for 48 hours (in order to prevent acute renal failure).
α-Glucosidase Inhibitors are linked to hyperglycemia with administered with the following drugs. If you have a patient with uncontrolled diabetes, the first question should be, “What other medication are you taking?” Because oftentimes, it interaction and not due to noncompliance. As thyroid and antiepileptic medications are life-long drugs, it’s critical to ask these types of questions. Side effects of sulfonylureas are blood based and include agranulocytosis (severe leukopenia), hemolytic anemia (destruction of red blood cells) and thrombocytopenia (low platelet count). So, if you have a patient who has a blood disorder, this drug class might not be the best match. Side effects of meglitinides focus on headache, low blood glucose, dizziness and weight gain. While side effects of biguanides focus on the GI tract (bloating, nausea, cramping and diarrhea). Nursing concepts for antidiabetic agents include glucose metabolism and pharmacology. Let’s review. There are various mechanisms of actions with most focusing on the stimulation of insulin receptors and the decreased or delay of glucose production. Indications include lowering blood glucose levels, while contraindications revolve around hypoglycemia, liver/kidney disease and pregnancy. Interactions are plentiful and drug class based but include herbal supplements, diuretics and beta blockers (to name a few). And lastly, side effects are blood and GI tract based. Patient education is crucial as hyper- and hypo- glycemia can cause serious complications. And now you know all you need to know about antidiabetic oral agents. Now go out and be your best self and as always happy nursing!
Tiona RN
Concepts Covered:
- Studying
- Medication Administration
- Adult
- Emergency Care of the Cardiac Patient
- Intraoperative Nursing
- Microbiology
- Cardiac Disorders
- Vascular Disorders
- Nervous System
- Upper GI Disorders
- Central Nervous System Disorders – Brain
- Immunological Disorders
- Fundamentals of Emergency Nursing
- Dosage Calculations
- Understanding Society
- Circulatory System
- Concepts of Pharmacology
- Hematologic Disorders
- Newborn Care
- Adulthood Growth and Development
- Disorders of Pancreas
- Postoperative Nursing
- Pregnancy Risks
- Neurological
- Postpartum Complications
- Noninfectious Respiratory Disorder
- Peripheral Nervous System Disorders
- Learning Pharmacology
- Prenatal Concepts
- Tissues and Glands
- Developmental Considerations
- Factors Influencing Community Health
- Childhood Growth and Development
- Prenatal and Neonatal Growth and Development
- Developmental Theories
- Basic
- Neonatal
- Pediatric
- Gastrointestinal
- Newborn Complications
- Labor Complications
- Fetal Development
- Terminology
- Labor and Delivery
- Postpartum Care
- Communication
- Basics of Mathematics
- Statistics
- Basics of Sociology
- Cardiovascular
- Shock
- Shock
- Disorders of the Posterior Pituitary Gland
- Endocrine
- Disorders of the Thyroid & Parathyroid Glands
- Liver & Gallbladder Disorders
- Lower GI Disorders
- Respiratory
- Delegation
- Perioperative Nursing Roles
- Acute & Chronic Renal Disorders
- Respiratory Emergencies
- Disorders of the Adrenal Gland
- Documentation and Communication
- Preoperative Nursing
- Legal and Ethical Issues
- Oncology Disorders
- Female Reproductive Disorders
- Musculoskeletal Trauma
- Renal Disorders
- Male Reproductive Disorders
- Sexually Transmitted Infections
- Infectious Respiratory Disorder
- Integumentary Disorders
- Emergency Care of the Trauma Patient
- Urinary Disorders
- Musculoskeletal Disorders
- EENT Disorders
- Neurological Emergencies
- Disorders of Thermoregulation
- Neurological Trauma
- Basics of NCLEX
- Integumentary Important Points
- Multisystem
- Test Taking Strategies
- Urinary System
- Emergency Care of the Neurological Patient
- Central Nervous System Disorders – Spinal Cord
- Respiratory System
- Emergency Care of the Respiratory Patient
- Cognitive Disorders
- Anxiety Disorders
- Depressive Disorders
- Trauma-Stress Disorders
- Substance Abuse Disorders
- Bipolar Disorders
- Psychotic Disorders
- Concepts of Mental Health
- Eating Disorders
- Personality Disorders
- Health & Stress
- Psychological Emergencies
- Somatoform Disorders
- Prioritization
- Community Health Overview
- Gastrointestinal Disorders
- Integumentary Disorders
- Respiratory Disorders
- Neurologic and Cognitive Disorders
- Renal and Urinary Disorders
- Infectious Disease Disorders
- EENT Disorders
- Hematologic Disorders
- Cardiovascular Disorders
- Musculoskeletal Disorders
- Endocrine and Metabolic Disorders
- Oncologic Disorders
- Behavior
- Emotions and Motivation
- Growth & Development
- Intelligence and Language
- Psychological Disorders
- State of Consciousness
- Note Taking
- Concepts of Population Health
- Basics of Human Biology